Phenobarbital Oral Solution
Monograph under this new title to become official June 1,2005
(Current monograph title is Phenobarbital Elixir)
»Phenobarbital Oral Solution contains not less than 90.0percent and not more than 110.0percent of the labeled amount of phenobarbital (C12H12N2O3).
Packaging and storage
Preserve in tight,light-resistant containers.
Identification
A:
Place 10mLof Oral Solution in a separator containing 20mLof water,add 5mLof 1Nsodium hydroxide,and extract with two 10-mLportions of chloroform,discarding the chloroform extracts.Add 5mLof 3Nhydrochloric acid,and extract with two 25-mLportions of chloroform,filtering the extracts through paper into a beaker.Remove the chloroform by evaporation on a steam bath,and dry the residue at 105for 2hours:the residue so obtained meets the requirements for Identificationtest Aunder Phenobarbital.
B:
The retention time of the major peak in the chromatogram of the Assay preparationcorresponds to that in the chromatogram of the Standard preparation,both relative to the internal standard,as obtained in the Assay.
Assay
pH4.5Buffer solution,Mobile phase,andChromatographic system
Prepare as directed in the Assayunder Phenobarbital.
Diluent
Prepare a mixture of methanol and pH4.5Buffer solution(2:1).
Internal standard solution
Dissolve a sufficient quantity of caffeine in Diluentto obtain a solution having a concentration of about 1.7mg per mL.
Standard preparation
Transfer about 33mg of USP Phenobarbital RS,accurately weighed,to a 25-mLvolumetric flask containing 2.0mLof Internal standard solution.Dilute with Diluentto volume,and mix.
Assay preparation
Transfer a quantity of Oral Solution,equivalent to about 33mg of phenobarbital,to a 25-mLvolumetric flask containing 2.0mLof Internal standard solution.Dilute with Diluentto volume,and mix.
Procedure
Proceed as directed for Procedurein the Assayunder Phenobarbital.Calculate the quantity,in mg,of phenobarbital (C12H12N2O3)in the portion of the Oral Solution taken by the formula:
W(RU/RS),
in which the terms are as defined therein.
(Official June 1,2005)
Auxiliary Information
Staff Liaison:Ravi Ravichandran,Ph.D.,Senior Scientist
Expert Committee:(PA3)Pharmaceutical Analysis 3
USP28NF23Page 1530
Pharmacopeial Forum:Volume No.28(2)Page 343
Phone Number:1-301-816-8330
|